Results for Antibiotic Therapy

Dr. Gmuca seeks to enhance the care of children with chronic musculoskeletal pain. Her current research addresses amplified musculoskeletal pain syndrome, which is a major public health issue because of its high prevalence, related socioeconomic burden, and associated risk of opioid exposure. Dr. Gmuca’s work aims to identify innovative strategies to improve long-term treatment outcomes for this patient population.

Dr. Fitzgerald's research focuses on the impact of pediatric sepsis on renal dysfunction. She examines biomarkers that may be helpful in predicting renal dysfunction in septic acute kidney injury, and the impact of resuscitative therapies and pharmacometrics in sepsis on the development of sepsis-related renal dysfunction.

Dr. Mukhopadhyay’s research interests include neonatal infectious disease epidemiology, the developing microbiome and the effect of these early-life factors on later childhood health outcomes.